Nonobstructive Coronary Lesions and Ventricular Dysfunction

Many patients arrive to the cath lab for a diagnostic coronary angiography after an echo showing severe ventricular dysfunction, even in asymptomatic patients. In many occasions, their coronary arteries are normal, and in many others, we find coronary disease that is not enough to warrant such severe ventricular dysfunction.

Double Kissing Crush vs. Provisional Stenting

Patients with heart failure are frequently divided according to aetiology in ischemic and nonischemic. However, such binary classification combines patients with normal coronary arteries and patients with nonobstructive disease who might have a different prognosis.

This study divided patients with ventricular dysfunction into those with normal coronary arteries, nonobstructive disease, and obstructive disease.

The primary endpoint was a composite of cardiovascular death, nonfatal infarction, nonfatal stroke, and heart failure hospitalization.


Read also: The First Antidote Against Ticagrelor Is a Rapid-Acting, Extended Effect Agent in Preliminary Results.


Of 12,814 patients, 2656 (20.7%) had normal coronary arteries, 2254 (17.6%) had nonobstructive disease, and 7904 (61.7%) had obstructive disease.

The risk of the primary endpoint was significantly higher in the nonobstructive group (hazard ratio [HR]: 1.17; 95% confidence interval [CI]: 1.04 to 1.32; p = 0.01) compared with the group with normal coronary arteries.


Read also: Patients: What They Really Want to Know about Their Disease.


Nonobstructive coronary artery disease was associated with an increase in cardiovascular death (HR: 1.82; 95% CI: 1.27 to 2.62; p = 0.001) and all-cause mortality (HR: 1.18; 95% CI: 1.05 to 1.33; p = 0.005). Still, there were no differences as regards acute myocardial infarction, stroke, or heart failure hospitalization.

Conclusion

Among patients with left ventricular dysfunction, the presence of nonobstructive coronary artery disease was independently associated with an increase in composite events and mortality.

Original title: Importance of Nonobstructive Coronary Artery Disease in the Prognosis of Patients With Heart Failure.

Reference: Juarez R. Braga et al. J Am Coll Cardiol HF 2019, article in press.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...